By Joke Kujenya, 2026 Naija Watch Cancer Fellow QUESTIONS ABOUT a new personalised cancer vaccine have intensified following clinical trial results involving Merck and Moderna’s intismeran autogene, also known by the code names mRNA-4157 and V940. JKNewsMedia.com writes that Dr. Omolola Salako, an Oncologist at the College of Medicine, Idi-Ar...
